Related Experiment Video
Updated: Jul 21, 2026
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
The state of pediatric heart transplantation
1Inova Fairfax Hospital for Children, Falls Church, VA 22042, USA.
Insights
Pediatric heart transplantation offers hope for children but faces unique hurdles. Ongoing research aims to improve mechanical support, post-transplant care, and quality of life assessments for young recipients.
Area of Science:
- Pediatric cardiology
- Cardiovascular surgery
- Transplant medicine
Background:
- Heart transplantation is a recognized treatment for pediatric heart disease.
- Pediatric recipients present distinct challenges compared to adults.
- Congenital heart disease adds complexity to pediatric heart transplants.
Purpose of the Study:
- To review the unique challenges in pediatric heart transplantation.
- To highlight areas needing improvement in pediatric heart transplant care.
- To discuss the long-term considerations for pediatric transplant recipients.
Main Methods:
- Review of current literature on pediatric heart transplantation.
- Analysis of challenges in indications, surgical complexity, and mechanical support.
- Examination of post-transplant management issues and quality of life.
Main Results:
- Lack of effective mechanical support increases mortality risk for children awaiting transplants.
- Physiological differences complicate post-transplant management, including immunosuppression and infection control.
- Identifying transplant coronary artery disease and post-transplant lymphoproliferative disease are key concerns.
Conclusions:
- Pediatric heart transplantation is advancing positively.
- Significant areas for improvement exist in pediatric transplant care.
- Comprehensive quality of life measures are essential due to longer life expectancies.
Abstract:
Heart transplantation is now an accepted method for treatment of heart disease in children, but transplantation in pediatric recipients continues to present unique challenges. The differences in indications and the complexity of surgery for congenital heart disease are only two of those challenges. A successful means of mechanical support is not available, which puts children at special risk of dying while waiting for transplantation. In addition, physiologic differences produce issues about management after transplantation, including use of immunosuppressive agents, control of infection, identification of transplant coronary artery disease, and posttransplant lymphoproliferative disease. Because of the longer life expectancy desired from pediatric transplantation, measurement of quality of life must be more comprehensive. This broad range of special demands means that although the state of pediatric heart transplantation is positive, there are areas for continued improvement.
Related Concept Videos
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction